These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 13493432)

  • 1. [Theophylline-nucleoside therapy in coronary and cerebral circulatory disorders with parmanil].
    LOSCH J
    Munch Med Wochenschr; 1957 Nov; 99(45):1683-6. PubMed ID: 13493432
    [No Abstract]   [Full Text] [Related]  

  • 2. [Medical treatment of coronary and cerebral circulatory disorders].
    KONNER P
    Medizinische; 1958 Feb; 2(8):324-6. PubMed ID: 13516277
    [No Abstract]   [Full Text] [Related]  

  • 3. [Persantin, a new substance for therapy of coronary insufficiency].
    JUNEMANN P
    Munch Med Wochenschr; 1959 Feb; 101(8):340-1. PubMed ID: 13644100
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of coronary insufficiency with persantin].
    TETZLAFF H; TETZLAFF D
    Med Monatsschr; 1959 Apr; 13(4):229-31. PubMed ID: 13656374
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of coronary insufficiency with aprophen].
    MITEREV IuG
    Klin Med (Mosk); 1958 May; 36(5):138-9. PubMed ID: 13550696
    [No Abstract]   [Full Text] [Related]  

  • 6. The rationale of vasopressor treatment of cerebrovascular insufficiency and coronary insufficiency.
    WILLIAMS JH; CORDAY E
    Dis Chest; 1959 May; 35(5):561-4. PubMed ID: 13652766
    [No Abstract]   [Full Text] [Related]  

  • 7. [Medico-bibliographical review of coronary dilating drugs].
    PEDRINOLA V
    Arq Bras Cardiol; 1958 Sep; 11(3):167-74. PubMed ID: 13607245
    [No Abstract]   [Full Text] [Related]  

  • 8. [First observations on the therapeutic action of a new synthetic coronary vasokilator; 7-alpha-(acetoxyethane)-oxyflavone].
    TARTARA A; CORBETTA F
    Folia Cardiol; 1956 Oct; 15(5):539-49. PubMed ID: 13405097
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences with a new therapeutic agent for stenocardia].
    HANKE H
    Dtsch Med J; 1958 Aug; 9(8):432-3. PubMed ID: 13573972
    [No Abstract]   [Full Text] [Related]  

  • 10. An appraisal of methods of improving cerebral blood flow.
    PFEIFFER JP
    N C Med J; 1953 Nov; 14(11):564-9. PubMed ID: 13111610
    [No Abstract]   [Full Text] [Related]  

  • 11. [New treatment possibilities in coronary circulatory disorders and metabolism disorders of the myocardium with parmanil].
    GERSTNER K
    Munch Med Wochenschr; 1959 Dec; 101():2276-9. PubMed ID: 13827629
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of combination therapy of adenosine and nitroprusside with adenosine[correction for adensosine] alone in the treatment of angiographic no-reflow phenomenon: does 1 plus 1 equal 11?
    Bailey SR
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):492-3. PubMed ID: 15065144
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronary dilators and angina: reappraisal.
    SILBER EN; KATZ LN
    J Am Med Assoc; 1953 Nov; 153(12):1075-6. PubMed ID: 13096341
    [No Abstract]   [Full Text] [Related]  

  • 14. [New and authenticated theories from the area of theophylline and strophanthin therapy].
    THURAU H
    Med Klin; 1959 Mar; 54(10):419-21. PubMed ID: 13643600
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with parmanil in the treatment of circulatory insufficiency of the heart].
    NIEHAUS W
    Ther Ggw; 1959 Nov; 98():523-6. PubMed ID: 14427074
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic results of a new vasodilator in severe circulatory disorders of the lower extremities].
    WEGHAUPT K
    Wien Klin Wochenschr; 1957 Jan; 69(2):31-2. PubMed ID: 13409874
    [No Abstract]   [Full Text] [Related]  

  • 17. [Can cerebral sclerosis, sequelae and peripheral vascular disorders be treated medically].
    SCHENK H
    Med Klin; 1957 Oct; 52(43):1885-7. PubMed ID: 13483040
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical significance of a new spasmolytic kellidrin].
    EVERS C
    Munch Med Wochenschr; 1954 May; 96(20):592-5. PubMed ID: 13165608
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon.
    Barcin C; Denktas AE; Lennon RJ; Hammes L; Higano ST; Holmes DR; Garratt KN; Lerman A
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):484-91. PubMed ID: 15065143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cerebral sclerosis and its treatment with cosaldon].
    MEYER J
    Med Klin; 1957 Jun; 52(24):1073-4. PubMed ID: 13451071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.